Michael Gelband’s Alpine Immune Sciences Inc ALPN Stock Holding History

Michael Gelband’s Portfolio ALPN Stock Details ALPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-171,251	Closed	-$6.79M	–	2105
2024 Q1	$6.79M	Sell	171,251 -37,723	-18%	-$1.11M	0.05%	305
2023 Q4	$3.98M	Sell	208,974 -8,081	-4%	-$112K	0.03%	392
2023 Q3	$2.48M	Buy	217,055 +154,216	+245%	+$1.9M	0.02%	612
2023 Q2	$646K	Buy	+62,839	New	+$567K	0.01%	1265
2021 Q2	–	Sell	-36,359	Closed	-$385K	–	2928
2021 Q1	$385K	Sell	36,359 -53,870	-60%	-$672K	0.01%	1519
2020 Q4	$1.14M	Buy	+90,229	New	+$886K	0.01%	791

Michael Gelband's ALPN Position: Q2 2024 in Review

Michael Gelband sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2024, closing a stake of 171,251 shares — an estimated $6.79M sold.

Michael Gelband first reported a position in ALPN in Q4 2020 and held it in 6 quarters. The position peaked at $6.79M in Q1 2024. 0 funds tracked by Wall St. Rank hold ALPN as of Q2 2024.

Michael Gelband reported no remaining Alpine Immune Sciences Inc position as of Q2 2024 after selling out during the quarter.
Michael Gelband sold 171,251 Alpine Immune Sciences Inc shares in Q2 2024, an estimated $6.79M.
Michael Gelband first reported a position in Alpine Immune Sciences Inc in Q4 2020 and held it in 6 quarters.
Michael Gelband's Alpine Immune Sciences Inc position peaked at $6.79M in Q1 2024.
0 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2024.

Based on ExodusPoint Capital Management's 13F filing for Q2 2024, filed 13 Aug 2024.